Abstract

Essentials Zymogen PK is activated to PKa and cleaves substrates kininogen and FXII contributing to bradykinin generation.Monomeric PKa and dimeric homologue FXI utilize the N‐terminal apple domains to recruit substrates.A high‐resolution 1.3 Å structure of full‐length PKa reveals an active conformation of the protease and apple domains.The PKa protease and four‐apple domain disc organization is 180° rotated compared to FXI. SummaryBackgroundPlasma prekallikrein (PK) and factor XI (FXI) are apple domain‐containing serine proteases that when activated to PKa and FXIa cleave substrates kininogen, factor XII, and factor IX, respectively, directing plasma coagulation, bradykinin release, inflammation, and thrombosis pathways.ObjectiveTo investigate the three‐dimensional structure of full‐length PKa and perform a comparison with FXI.MethodsA series of recombinant full‐length PKa and FXI constructs and variants were developed and the crystal structures determined.Results and conclusionsA 1.3 Å structure of full‐length PKa reveals the protease domain positioned above a disc‐shaped assemblage of four apple domains in an active conformation. A comparison with the homologous FXI structure reveals the intramolecular disulfide and structural differences in the apple 4 domain that prevents dimer formation in PK as opposed to FXI. Two latchlike loops (LL1 and LL2) extend from the PKa protease domain to form interactions with the apple 1 and apple 3 domains, respectively. A major unexpected difference in the PKa structure compared to FXI is the 180° disc rotation of the apple domains relative to the protease domain. This results in a switched configuration of the latch loops such that LL2 interacts and buries portions of the apple 3 domain in the FXI zymogen whereas in PKa LL2 interacts with the apple 1 domain. Hydrogen‐deuterium exchange mass spectrometry on plasma purified human PK and PKa determined that regions of the apple 3 domain have increased surface exposure in PKa compared to the zymogen PK, suggesting conformational change upon activation.

Highlights

  • The regulation of extracellular proteolysis is critical to blood hemostasis and innate immunity and proteases plasma prekallikrein (PK), and coagulation factors XII (FXII) and XI (FXI) act as master regulators of several cascades including coagulation, fibrinolysis, complement activation, and inflammation [1,2,3,4]

  • A major unexpected difference in the plasma kallikrein (PKa) structure compared to factor XI (FXI) is the 180° disc rotation of the apple domains relative to the protease domain

  • This results in a switched configuration of the latch loops such that LL2 interacts and buries portions of the apple 3 domain in the FXI zymogen whereas in PKa LL2 interacts with the apple 1 domain

Read more

Summary

Introduction

The regulation of extracellular proteolysis is critical to blood hemostasis and innate immunity and proteases plasma prekallikrein (PK), and coagulation factors XII (FXII) and XI (FXI) act as master regulators of several cascades including coagulation, fibrinolysis, complement activation, and inflammation [1,2,3,4]. The PK zymogen can be activated by a single cleavage from two-chain factor XIIa (FXIIa) and can be activated with reduced efficiency by single-chain FXII [6]. The active form plasma kallikrein (PKa) performs a double cleavage of HK to liberate the vasoactive peptide bradykinin, which binds the G-protein coupled receptor (GPCR) B2R on endothelial cells leading to activation of signaling events. PKa is currently being targeted as a novel means to treat diverse thrombotic [12,13,14] and inflammatory disorders such as diabetic macular edema [15,16], desquamating skin diseases, and neurodegenerative disorders [12,17]

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call